Anne Li April 23rd, 2017
A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise. Results of various trials have been presented at the annual American Association for Cancer Research (AACR) conference in Washington, D.C. The findings follow initial excitement around the drugs in recent years, and make early estimates of the possible long term benefits for some patients. But questions still remain over which patients should receive the treatments, how extensive side effects are, and how to address where immunotherapy hasn’t been successful.
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-04-10-long-term-benefits-of-immunotherapy-emerging-for-some-patients-though-key-questions-remain